{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:02:24Z","timestamp":1753876944708,"version":"3.41.2"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972168"],"award-info":[{"award-number":["81972168"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Trial Program of Zhongshan Hospital","award":["ZSLC035"],"award-info":[{"award-number":["ZSLC035"]}]},{"name":"Shanghai Pujiang Program","award":["23PJD011"],"award-info":[{"award-number":["23PJD011"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>This study aimed to explore the possibility of positron emission tomography\/computed tomography (PET-CT) in identifying histological classification of thymic tumours.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>Patients diagnosed as thymic tumours and accepted PET-CT scans were included. Thymic tumours were classified into three subgroups: low-risk thymoma (A, AB and B1), high-risk thymoma (B2, B3) and thymic carcinoma (TC). Logistic regression analysis was performed to identify potential factors differentiating the classification of thymic tumours. The receiver operating characteristic curve was applied to assess the diagnosis efficiency and the cut-off value.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>From 2015 to 2023, a total of 176 patients, including 75 cases of low-risk thymoma, 60 cases of high-risk thymoma and 41 cases of TC, were included. The logistic regression models suggested maximum standardized uptake value (SUVmax) as a potential factor differentiating the three subgroups. Moreover, the receiver operating characteristic curve identified the SUVmax in differentiating low-risk thymoma vs high-risk thymoma (area under the curve [AUC]: 0.845, 95% CI: 0.776\u20130.913, specificity: 0.907, sensitivity: 0.716), low-risk thymoma vs TC (AUC: 0.976, 95% CI: 0.953\u20130.999, specificity: 0.933, sensitivity: 0.951) and high-risk thymoma vs TC (AUC: 0.84, 95% CI: 0.761\u20130.92, specificity: 0.865, sensitivity: 0.703), respectively. SUVmax was also an independent factor identifying thymic tumours with or without lymph node metastasis. The cut-off of 10 in SUVmax could well identify lymph node metastasis with the positive predict value of 0.684 and negative predict value of 0.981.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>SUVmax is a reliable factor in distinguishing different histological subgroups and identifying lymph node metastasis in thymic tumours.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/icvts\/ivaf065","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T18:54:11Z","timestamp":1741805651000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical significance of positron emission tomography-computed tomography in the classification of thymic tumors"],"prefix":"10.1093","volume":"40","author":[{"given":"Jian","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Zhongshan Hospital, Fudan University , Shanghai,","place":["China"]},{"name":"Cancer Center, Zhongshan Hospital, Fudan University , Shanghai,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Cancer Center, Zhongshan Hospital, Fudan University , Shanghai,","place":["China"]},{"name":"Department of Nuclear Medicine, Zhongshan Hospital, Fudan University , Shanghai,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Qiang","family":"Ao","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Zhongshan Hospital, Fudan University , Shanghai,","place":["China"]},{"name":"Cancer Center, Zhongshan Hospital, Fudan University , Shanghai,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Hao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Zhongshan Hospital, Fudan University , Shanghai,","place":["China"]},{"name":"Cancer Center, Zhongshan Hospital, Fudan University , Shanghai,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Zhongshan Hospital, Fudan University , Shanghai,","place":["China"]},{"name":"Cancer Center, Zhongshan Hospital, Fudan University , Shanghai,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Zhongshan Hospital, Fudan University , Shanghai,","place":["China"]},{"name":"Cancer Center, Zhongshan Hospital, Fudan University , Shanghai,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Cheng","family":"Shi","sequence":"additional","affiliation":[{"name":"Cancer Center, Zhongshan Hospital, Fudan University , Shanghai,","place":["China"]},{"name":"Department of Nuclear Medicine, Zhongshan Hospital, Fudan University , Shanghai,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Yong","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Zhongshan Hospital, Fudan University , Shanghai,","place":["China"]},{"name":"Cancer Center, Zhongshan Hospital, Fudan University , Shanghai,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"2025032209263104800_ivaf065-B1","doi-asserted-by":"crossref","first-page":"107446","DOI":"10.1016\/j.lungcan.2023.107446","article-title":"WHO histological classification and tumor size are predictors of the locally aggressive behavior of thymic epithelial tumors","volume":"187","author":"Gao","year":"2024","journal-title":"Lung Cancer"},{"key":"2025032209263104800_ivaf065-B2","doi-asserted-by":"crossref","first-page":"628534","DOI":"10.3389\/fonc.2021.628534","article-title":"CT-based radiomics signatures for predicting the risk categorization of thymic epithelial tumors","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"2025032209263104800_ivaf065-B3","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.jtho.2017.06.072","article-title":"Assessment of the ITMIG statement on the WHO histological classification and of the eighth TNM staging of thymic epithelial tumors of a series of 188 thymic epithelial tumors","volume":"12","author":"Meurgey","year":"2017","journal-title":"J Thorac Oncol"},{"key":"2025032209263104800_ivaf065-B4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/PAS.0000000000000391","article-title":"Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on prognosis","volume":"39","author":"Roden","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"2025032209263104800_ivaf065-B5","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1097\/JTO.0000000000000293","article-title":"The ITMIG\/IASLC thymic epithelial tumors staging project: a proposed lymph node map for thymic epithelial tumors in the forthcoming 8th edition of the TNM classification of malignant tumors","volume":"9","author":"Bhora","year":"2014","journal-title":"J Thorac Oncol"},{"key":"2025032209263104800_ivaf065-B6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/icvts\/ivx116","article-title":"Lymph node metastases in thymic malignancies: a Chinese Alliance for Research in Thymomas retrospective database analysis","volume":"25","author":"Gu","year":"2017","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025032209263104800_ivaf065-B7","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jtcvs.2018.04.049","article-title":"Lymph node metastasis in thymic malignancies: a Chinese multicenter prospective observational study","volume":"156","author":"Fang","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025032209263104800_ivaf065-B8","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.3390\/cancers13236091","article-title":"Current roles of PET\/CT in thymic epithelial tumours: which evidences and which prospects? A pictorial review","volume":"13","author":"Lococo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025032209263104800_ivaf065-B9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11748-020-01439-7","article-title":"18F-FDG-PET\/CT predicts grade of malignancy and invasive potential of thymic epithelial tumors","volume":"69","author":"Ito","year":"2021","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2025032209263104800_ivaf065-B10","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/JTO.0000000000000654","article-title":"The 2015 World Health Organization classification of tumors of the thymus: continuity and changes","volume":"10","author":"Marx","year":"2015","journal-title":"J Thorac Oncol"},{"key":"2025032209263104800_ivaf065-B11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cpet.2020.09.007","article-title":"Total-body PET\/computed tomography highlights in clinical practice: experiences from Zhongshan Hospital, Fudan University","volume":"16","author":"Sui","year":"2021","journal-title":"PET Clin"},{"key":"2025032209263104800_ivaf065-B12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/icvts\/ivy102","article-title":"Statistical primer: how to deal with missing data in scientific research?","volume":"27","author":"Papageorgiou","year":"2018","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025032209263104800_ivaf065-B13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.lungcan.2014.08.008","article-title":"Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis","volume":"86","author":"Treglia","year":"2014","journal-title":"Lung Cancer"},{"key":"2025032209263104800_ivaf065-B14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.lungcan.2016.07.025","article-title":"Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor","volume":"100","author":"Moon","year":"2016","journal-title":"Lung Cancer"},{"key":"2025032209263104800_ivaf065-B15","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1007\/s00268-017-3938-2","article-title":"The role of (18)F-fluorodeoxyglucose positron emission tomography-computed tomography for predicting pathologic response after induction therapy for thymic epithelial tumors","volume":"41","author":"Fukumoto","year":"2017","journal-title":"World J Surg"},{"key":"2025032209263104800_ivaf065-B16","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00330-021-08230-z","article-title":"Diagnostic and prognostic values of 2-[(18)F]FDG PET\/CT in resectable thymic epithelial tumour","volume":"32","author":"Han","year":"2022","journal-title":"Eur Radiol"},{"key":"2025032209263104800_ivaf065-B17","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1093\/ejcts\/ezt263","article-title":"18F-fluorodeoxyglucose positron emission tomography\/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1\u03b1, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours","volume":"44","author":"Toba","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025032209263104800_ivaf065-B18","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0003-4975(03)01017-8","article-title":"Lymphogenous and hematogenous metastasis of thymic epithelial tumors","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"}],"container-title":["Interdisciplinary CardioVascular and Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/icvts\/advance-article-pdf\/doi\/10.1093\/icvts\/ivaf065\/62387361\/ivaf065.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/icvts\/article-pdf\/40\/3\/ivaf065\/62387361\/ivaf065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/icvts\/article-pdf\/40\/3\/ivaf065\/62387361\/ivaf065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T11:27:02Z","timestamp":1742729222000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/icvts\/article\/doi\/10.1093\/icvts\/ivaf065\/8071871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,5]]}},"URL":"https:\/\/doi.org\/10.1093\/icvts\/ivaf065","relation":{},"ISSN":["2753-670X"],"issn-type":[{"type":"electronic","value":"2753-670X"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2025,3]]},"article-number":"ivaf065"}}